Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Interest Income, Other

2.8 / 5 stars · 68/120 Roast Me

Citius Pharmaceuticals, Inc. Interest Income, Other

Citius Pharmaceuticals, Inc. (CTXR) reported Interest Income, Other of $59.92 thousand for the 12-month period ending 2021-09-30, per its 10-K filed 2022-12-22.

Discontinued › Income Statement › Other Income

us-gaap:InterestIncomeOther · last filed 2022-12-22

  • Citius Pharmaceuticals, Inc. interest income, other for the quarter ending 2021-09-30 was $0.00.
  • Citius Pharmaceuticals, Inc. interest income, other for the quarter ending 2021-06-30 was $59.92K.
  • Citius Pharmaceuticals, Inc. interest income, other for fiscal 2021 was $59.92K.
Period endInterest Income, Other 3 monthInterest Income, Other 6 monthInterest Income, Other 9 monthInterest Income, Other 12 month
2021-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22
$59.92K
derived: sum of 2 quarters · filed 2022-12-22
$59.92K
10-K · filed 2022-12-22
2021-06-30$59.92K
10-Q · filed 2022-08-11
$59.92K
10-Q · filed 2022-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36